NCT04915131View on ClinicalTrials.gov

A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring

NACompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

April 28, 2022

Study Completion Date

May 5, 2022

Conditions

Fetal Monitoring

Interventions

DEVICE

Bloomlife MFM-Pro

"Bloomlife MFM-Pro is a non-invasive, wireless, external monitoring system used to measure fetal heart rate and maternal heart rate on pregnant women with a singleton pregnancy.~The system acquires biopotential signals from abdominal surface electrodes."

Trial Locations (2)

70115

Ochsner, New Orleans

85004

Valley Perinatal Services, Phoenix